Earkart IPO: Price, GMP, Allotment, and Details

Earkart IPO – Company Analysis

Earkart IPO is a fixed price issue of Rs. 49.26 Cr (0.36 crore shares) by Earkart Limited. This healthcare technology business specializes in audiology and hearing aids. Remote audiometry and hearing aid programming are made possible by its flagship product, the Earkart OMNI audiometer.

Additionally, the business offers audiology exams and hearing aids through its Shop-in-Shop (SIS) strategy, which includes ENT clinics and optical stores. Earkart now runs 49 SIS clinics in 22 cities as of 2025, with ambitions to grow to 510 clinics by FY27.

Earkart IPO Details

The Earkart IPO date is from Sep 25 to Sep 29, with IPO allotment on Sep 30, refund initiation on Oct 01, 2025. Earkart IPO price is Rs. 135.

Event	Date
IPO Open Date	September 25, 2025
IPO Close Date	September 29, 2025
IPO Allotment Date	September 30, 2025
Refunds / Credit of Shares	October 01, 2025
IPO Listing Date	October 03, 2025
Issue Type	Fixed Price Issue (SME IPO)
IPO Price Band	Rs. 135
Minimum Investment (Retail)	Rs. 2,70,000 (2000 Shares)
Listing At	BSE, SME

 

If you want to apply for the IPO, click to open a Demat Account.

 

 

Company Financial 

(Amount in Cr)

Period	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	30.29	19.25	14.73
Total Income	43.19	31.97	28.97
Profit After Tax	6.88	3.06	1.31
EBITDA	9.76	3.55	1.61
Net Worth	19.92	13.03	6.56
Reserves & Surplus	9.48	12.97	6.49
Total Borrowing	4.96	4	1.21

 

Earkart IPO Allotment Status and Allotment Date

The Earkart IPO allotment date is on 30 September 2025. Investors can check Earkart IPO allotment status using the registrar, Skyline Financial Services Pvt Ltd. or using the BSE Website- ​BSE IPO allotment status.

 

Earkart IPO GMP (Grey Market Premium)

The Earkart IPO GMP today is Rs. 0 as of 25 Sep 2025, while writing this information.  

 

Conclusion

Earkart Limited has proposed and is in the process of launching its innovative healthcare technology IPO. They have seen strong revenue growth while expanding their profit margins due to their SIS clinic model. Their growing profitability is attributed to the sales of their unique Omniaudiology Devices. As a result, the Earkart IPO is likely to appeal to investors looking both for listing gains and for those seeking to invest for the long term.  

 

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company Click Here to Download the DRHP.

Click Here To Stay Updated With The Upcoming IPOs.

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.